Host–Microbiome Relationship with Cardiometabolic Disorders
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (20 October 2023) | Viewed by 193
Special Issue Editors
Interests: gut microbiome; metabolic syndrome; oncology; chemotherapy; infections; antibiotic resistance
Special Issues, Collections and Topics in MDPI journals
Interests: vascular medicine; cardiovascular disease; hypertension; atherosclerosis; metabolic syndrome; arterial stiffness; vascular ageing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thousands of different microbial species inhabit the human body, and they have a strategic role in maintaining host homeostasis. In this context, the gut microbiome is one of the most studied and metabolically dynamic ecosystems known for producing a large and diverse repertoire of small bioactive molecules through the metabolism of dietary or host-derived compounds. For these reasons, the gut microbiome has the potential to exert a strong influence on multiple aspects of our physiology, from energy balance and metabolic regulation to the development and functioning of the immune, endocrine, and nervous systems. Gut microbial dysbiosis has been associated with a higher risk of developing metabolic disorders including cardiovascular disorders, obesity, type 2 diabetes, and nonalcoholic fatty acid disease. However, the mechanisms underlying these connections, as well as the involvement of other microbial ecosystems—besides that of the intestine—still need to be investigated through novel approaches while also targeting the in silico, in vitro, and in vivo functionality of microbes.
This Special Issue “Host-Microbiome Relationship with Cardiometabolic Disorders” will focus on the role of the human microbiome in maintaining host metabolic homeostasis, the mechanisms underlying the breaking of the microbiome–host crosstalk, as well as patient clinical outcomes.
Authors are invited to submit original research and review papers addressing these topics.
Dr. Federica D'Amico
Dr. Davide Agnoletti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbiome
- gut microbiota
- metabolic syndrome
- cardiovascular disease
- obesity
- T2D
- dysbiosis
- microbiome–host interactions
- clinical outcomes
